GLP-1 and Parkinson’s Disease: What the Evidence Shows
neurology
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications originally developed to manage type 2 diabetes and, in some regions, chronic weight. They influence insulin rel...
Open article